Rick DoblinEvery podcast appearance, updated as new ones drop

Dr. Rick Doblin (founder and president of the Multidisciplinary Association for Psychedelic Studies, and one of the most influential figures in psychedelic science) returns to Mayim Bialik's Breakdown for one of the most controversial and eye-opening conversations on psychedelics we've had yet. From the shocking experiment where scientists gave MDMA to an octopus, to why ibogaine may be the most powerful AND dangerous psychedelic ever studied, this episode explores the future of psychedelic therapy, trauma healing, addiction recovery, policy reform, and human consciousness itself. We break down Trump’s new executive order accelerating psychedelic research and what it could mean for the future legalization of psychedelic-assisted therapy in America. Dr. Doblin explains why veterans suffering from PTSD and disabilities have become central to bipartisan support for psychedelics, and why this issue is now reshaping politics on both sides of the aisle. We also dive deep into ibogaine: its mysterious origins, its ability to help reset opioid addiction, its connection to ancestral memory and intergenerational trauma, why it carries serious risks, and why Dr. Doblin still believes its benefits may outweigh the dangers. He also shares his own profound ibogaine experience that helped him confront perfectionism and his fear of death. Dr. Doblin discusses: - How psychedelics help people integrate trauma - Why psychedelics are generally considered non-addictive - Difference between recreational vs therapeutic psychedelic use - Why psychedelic treatment should be customized to each patient - Importance of integration, peer support, and paying attention to dreams after treatment - Measures of success in MDMA-assisted couples therapy - Origins of the opioid epidemic - "Psychedelic churches": How organizations are openly operating under the umbrella of religion - Capitalism vs democratizing the benefits of psychedelic medicine - How a better psychedelic therapy model could be built - Why transparency is critical for science-backed drug policy reform - When psychedelics may realistically enter the open market - Dr. Doblin’s long-term vision for a psychedelic-informed public As psychedelic research rapidly expands worldwide, this conversation explores the science, politics, risks, ethics, and revolutionary potential behind one of the fastest-growing movements in mental health and medicine! DISCLAIMER: MBB is not providing medical or legal advice. Listeners should speak to their doctor before engaging in any course of psychedelic protocols. Psychedelics are still illegal in many places - MBB is not encouraging engaging in illegal substance use, but simply sharing the latest scientific insights from our guests. Learn more about MAPS & their research: https://maps.org/ To learn more about the world’s largest psychedelic conference, Psychedelic Science , taking place in Denver, CO next year, visit: https://virtualtrip.maps.org/ Follow us on Substack for Exclusive Bonus Content: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://bialikbreakdown.substack.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BialikBrea

Dr. Rick Doblin (founder and president of the Multidisciplinary Association for Psychedelic Studies, and one of the most influential figures in psychedelic science) returns to Mayim Bialik's Breakdown for one of the most controversial and eye-opening conversations on psychedelics we've had yet. From the shocking experiment where scientists gave MDMA to an octopus, to why ibogaine may be the most powerful AND dangerous psychedelic ever studied, this episode explores the future of psychedelic therapy, trauma healing, addiction recovery, policy reform, and human consciousness itself. We break down Trump’s new executive order accelerating psychedelic research and what it could mean for the future legalization of psychedelic-assisted therapy in America. Dr. Doblin explains why veterans suffering from PTSD and disabilities have become central to bipartisan support for psychedelics, and why this issue is now reshaping politics on both sides of the aisle. We also dive deep into ibogaine: its mysterious origins, its ability to help reset opioid addiction, its connection to ancestral memory and intergenerational trauma, why it carries serious risks, and why Dr. Doblin still believes its benefits may outweigh the dangers. He also shares his own profound ibogaine experience that helped him confront perfectionism and his fear of death. Dr. Doblin discusses: - How psychedelics help people integrate trauma - Why psychedelics are generally considered non-addictive - Difference between recreational vs therapeutic psychedelic use - Why psychedelic treatment should be customized to each patient - Importance of integration, peer support, and paying attention to dreams after treatment - Measures of success in MDMA-assisted couples therapy - Origins of the opioid epidemic - "Psychedelic churches": How organizations are openly operating under the umbrella of religion - Capitalism vs democratizing the benefits of psychedelic medicine - How a better psychedelic therapy model could be built - Why transparency is critical for science-backed drug policy reform - When psychedelics may realistically enter the open market - Dr. Doblin’s long-term vision for a psychedelic-informed public As psychedelic research rapidly expands worldwide, this conversation explores the science, politics, risks, ethics, and revolutionary potential behind one of the fastest-growing movements in mental health and medicine! DISCLAIMER: MBB is not providing medical or legal advice. Listeners should speak to their doctor before engaging in any course of psychedelic protocols. Psychedelics are still illegal in many places - MBB is not encouraging engaging in illegal substance use, but simply sharing the latest scientific insights from our guests. Learn more about MAPS & their research: https://maps.org/ To learn more about the world’s largest psychedelic conference, Psychedelic Science , taking place in Denver, CO next year, visit: https://virtualtrip.maps.org/ Rula patients typically pay $15 per session when using insurance. Connect with quality therapists and mental health experts who specialize in you at https://www.rula.com/break/ #rulapod Text BREAKDOWN to 64000 to get 20% off all IQBAR products, plus FREE shipping. Message and data rates may apply. Head to https://www.Superpower.com and use code BREAK at checkout for $20 off your membership. Unlock your new health intel

In this episode of the Ayahuasca Podcast, host Sam Believ sits down with Rick Doblin, Ph.D., the visionary founder of MAPS (Multidisciplinary Association for Psychedelic Studies). Rick has spent over 40 years leading the "Psychedelic Renaissance," moving MDMA through rigorous FDA clinical trials to treat PTSD and advocating for a post-prohibition world. Rick shares his profound journey—from a draft resistor in the 70s to a global leader in drug policy—explaining why he believes humanity is currently in a "race between consciousness and catastrophe." Key Discussion Points 04:15 – The Origins of Passion: Rick describes his upbringing in the shadow of the Holocaust and the Cuban Missile Crisis, which led to a lifelong quest to bridge the gap between human intellectual power and spiritual maturity. 09:30 – The Bar Mitzvah That Wasn't: Why Rick’s first LSD trip at 17 felt like the true "rite of passage" his traditional Bar Mitzvah failed to provide, sparking his interest in ancient transformative rituals. 13:45 – The "Hitler Within": A vulnerable recount of a DMT and Ketamine sequence in 1984 where Rick realized that the capacity for evil exists within everyone, leading to his mission for "mass mental health." 18:20 – The Birth of MAPS (1986): Navigating the DEA crackdowns of the 80s and deciding that medicalization through the FDA was the only viable path forward for psychedelics. 24:50 – A Global "Ayahuasca Day"? Sam and Rick discuss the potential of cultural integration—moving psychedelics from the counterculture to the mainstream as a tool for societal sanity. 29:10 – The Inflection Point: Rick reflects on the irony of President Trump’s executive order to accelerate psychedelic approvals and what it means for bipartisan support. 34:00 – Inner Work as a Global Necessity: Discussing Carl Jung’s warning that "the only real danger now is man himself" and how psychedelics can help us manage our own destructive capacities. 39:15 – Post-Apocalyptic Utopia: Exploring the vision of a world where technology handles labor, leaving humanity to focus on poetry, art, music, and consciousness. The MAPS Strategy: From Criminal to Clinical Rick explains that the strategy for the last 40 years has been to "go where the suffering is." By focusing on treatment-resistant PTSD, MAPS has been able to show that these substances are not just "party drugs" but powerful tools for clinical healing. The Race Between Consciousness and Catastrophe Rick posits that as our technological capabilities (AI, nuclear energy, etc.) grow, our emotional and spiritual development must keep pace. Without a shift in consciousness, our advancements become tools for destruction. Learn more about Rick Doblin and MAPS: Website: maps.org Rick’s TED Talk: The future of psychedelic-assisted psychotherapy Experience Authentic Healing: Are you seeking your own "inner transformation"? Visit ayahuascaincolombia.com to learn about our retreats in the heart of Colombia.

Can MDMA-assisted therapy solve the world’s most deep-seated conflicts? In this episode of Talks 21, we sit down with Rick Doblin, the visionary founder of MAPS (Multidisciplinary Association for Psychedelic Studies). Rick has spent over 40 years working tirelessly to transitionpsychedelics from counterculture to FDA-approved medicine. We dive deep into Rick’s personal journey – from his first encounters with LSD and the influence of Stan Grof, to his strategic battle against the DEA and the founding of MAPS in 1986. Rick candidly shares the mistakes made during the commercialisation of MDMA and his radical vision for "Net Zero Trauma" by 2070. Whether you are interested in the science of healing, the politics of drug reform, or the potential for psychedelics to foster peace in regions like Israel and Palestine, this conversation offers a profound look at the courage required to change the world. In this episode, we discuss: 🔹 The impact of the Holocaust and the Vietnam War on Rick’s mission. 🔹 The strategic shift from individual therapy to cultural and policy change. 🔹 The current status of the FDA approval for MDMA in the United States. 🔹 How to build bridges with those who think differently to find common ground. 🔹 Rick’s philosophy: focus on effort over outcome to build a lasting legacy. 🔗 You can support MAPS by sharing resources, joining upcoming events, or participating in their educational programs. Consider engaging in community conversations, volunteering, or supporting ongoing research to help shape the future of psychedelic medicine : www.maps.org Chapters 0:00:00 Theme song 0:00:13 Introduction 00:01:32 Rick’s Path to Psychedelics 00:18:22 Shifting Focus: From Individual Therapy to Public Policy 00:25:02 The Biggest Mistake in Building MAPS 00:31:46 The Future of MDMA Approval in the United States 00:34:58 A Vision for 2070: Achieving Net Zero Trauma 00:45:21 Healing Global Conflicts with MDMA 00:51:13 How to Overcome Fear and Spread Courage 01:03:45 Rick Doblin’s Legacy and Life’s Work 🔔 Subscribe to the channel and watch more interviews: https://www.youtube.com/channel/UCaJaxm7F1tK58bEnVoVliqg?sub_confirmation=1 Listen to the Talks 21 podcast also on: 🎧 Spotify → https://bit.ly/spotify-talks21 🎧 Apple Podcasts → https://apple.co/3VWWzwv 🌐 Official website of Karel Janeček: https://www.kareljanecek.com 📲 Follow Karel Janeček on social media: Instagram → https://www.instagram.com/karel252/ Facebook → https://www.facebook.com/kareljanecekcz 📩 Want to receive new episodes by email? Subscribe to the newsletter on the website. 💬 Do you have a guest suggestion or feedback? Write to us at: media@kareljanecek.com

Mental health conditions like depression, PTSD, and trauma related disorders remain difficult to treat, especially when underlying cognitive and emotional patterns persist over time. Emerging research suggests psychedelic assisted therapies may work by temporarily changing how the brain processes information and the sense of self. In this episode of Extend, we continue our conversation with Dr. Rick Doblin, founder of MAPS, to explore the mechanisms behind psychedelic therapy. We break down how compounds like LSD may reduce activity in the default mode network, how this shift affects perception and emotional processing, and why integration is essential for translating short term insights into lasting change. We also explore how traditional practices like ayahuasca combine psychological and spiritual frameworks, and how these approaches are shaping new perspectives on trauma, behavior change, and mental health treatment. Dr. Rick Doblin is the founder and executive director of MAPS (Multidisciplinary Association for Psychedelic Studies), the organization leading global research into psychedelic assisted therapies and working to develop evidence-based treatments for PTSD and other mental health conditions. What We Discuss: (1:01:22) LSD therapy for trauma and addiction (1:10:10) Psilocybin, creativity, and cognition (1:12:05) DMT, ego dissolution, and consciousness (1:18:21) Ayahuasca traditions and addiction recovery (1:26:39) MDMA therapy and intergenerational trauma (1:31:36) Ketamine clinics and treatment resistant depression Thank You to Our Sponsors: Timeline: Go to timeline.com/drshah to get 20% off your order. Learn more about Dr. Shah: Website: drshah.com Clinic: next-health.com Instagram: darshanshahmd Learn more about Dr. Rick Doblin: Website: maps.org Instagram: rickdoblinphd X: @RickDoblin

Depression, PTSD, and trauma related disorders continue to challenge modern medicine, even as our understanding of the brain and consciousness rapidly evolves. New research suggests that certain therapies may help unlock deeper healing by combining neuroscience, psychology, and carefully guided experiences. In this episode of Extend, we sit down with Dr. Rick Doblin, founder of MAPS, to unpack the science and history behind psychedelic assisted therapy and its potential role in mental health treatment. We break down the research behind MDMA assisted therapy for PTSD, how psychedelics influence neuroplasticity and emotional processing, and why therapeutic context, preparation, and integration are essential for safe and meaningful outcomes. We also explore how psychedelic research is reshaping conversations around trauma, healing, and the future of psychiatry. Dr. Rick Doblin is the founder and executive director of MAPS (Multidisciplinary Association for Psychedelic Studies), the organization leading global research into psychedelic assisted therapies and working to develop evidence-based treatments for PTSD and other mental health conditions. What We Discuss: (01:55) The political origins of psychedelic prohibition (04:40) Ancient psychedelic traditions and the Eleusinian Mysteries (08:01) Dr. Rick Doblin's path to founding MAPS (10:34) Science, policy, and the future of psychedelic medicine (11:00) Expanding research on MDMA therapy (12:21) Psychedelic churches and religious freedom laws (15:42) Why context and safety shape psychedelic outcomes (16:20) Neuroplasticity and emotional processing (17:36) Bromo-LSD and non-psychedelic therapeutic compounds (20:39) Psychedelics and rewriting personal narratives (23:22) The Good Friday Experiment and mystical experiences (25:23) MDMA therapy and trauma processing (27:47) Psychedelics and alternatives to alcohol (30:30) Ketamine therapy and pharmaceutical incentives (36:16) MAPS, MDMA development, and commercialization (41:56) The FDA pathway for MDMA therapy (47:00) Global psychedelic research initiatives (56:51) Early LSD research in psychology …to be continued Thank You to Our Sponsors: Timeline: Timeline powered by Mitopure just dropped the price. Check it out at timeline.com/drshah and get an additional 20% off your first month with code DRSHAH. Learn more about Dr. Shah: Website: <a href= "https://www.

What happens when science, healing, and culture finally meet in the same room, and something genuinely new becomes possible? I recently returned from the MAPS Psychedelic Science Conference in Denver, and I can honestly say it felt like a turning point. What gathered there wasn’t just a community of researchers or clinicians, but a broad and unlikely coalition, scientists, veterans, therapists, policymakers, spiritual leaders, and people from across the political spectrum, coming together around a shared commitment to healing. In a time marked by division and uncertainty, the atmosphere was unmistakably hopeful. In my conversation with Dr. Rick Doblin, founder and president of MAPS, we explore why this moment feels different from past psychedelic waves. We talk about the groundbreaking Phase 3 research on MDMA-assisted therapy for PTSD, the remarkable engagement and outcomes from clinical trials, and the parallel paths of medicalization and decriminalization that are shaping the future of this work. More than anything, this episode is about what becomes possible when we move beyond stigma and fear and begin to integrate these medicines with care, rigor, and compassion. We Also Discuss: ● The psychedelic movement becoming truly bipartisan ● MDMA-assisted therapy showing unprecedented PTSD outcomes ● Why engagement in treatment matters as much as efficacy ● Psychedelics inviting healing at the root, not just symptom relief ● The safe containers that allow truth-telling and integration Key Timestamps: [0:00:00] Welcome to The Radical Responsibility Podcast [0:02:24] Setbacks encountered for rescheduling MDMA [0:13:55] Psychedelic legalization and destigmatization. [0:23:22] Insurance coverage for MDMA therapy. [0:28:01] The “right to try” for controlled substances. [0:36:11] MAPS’ involvement in today’s pressing humanitarian issues. [0:48:26] Culture and its impact on the acceptance of psychedelics. [0:54:44] Opinion on licensing fror psychedelic legalization. [01:02:52] Psychedelics and how it relates to positive changes in consciousness. [01:11:35] What would be happening now if MDMA got approved? Become a Heart Mind Community Member and access ALL our past and future summits plus a thriving private community: https://www.heartmind.co/podcastoffer Download your free Neuro-Somatic Mindfulness E-Book by Dr. Fleet Maull: https://www.heartmind.co/nsm-podcast Order “Radical Responsibility” by Fleet Maull and get $1,088 in free bonuses today including courses and challenges: https://www.radicalresponsibilitybook.com/ Connect with Rick Doblin: Instagram: https://www.instagram.com/rickdoblinphd/?hl=en Facebook: https://www.facebook.com/rickdoblin/ X: https://x.com/RickDoblin Join our Facebook group: https://www.facebook.com/groups/hmisummitcommunity Follow us on Instagram: https://www.instagram.com/heartmindinstitute Follow us on Facebook: https://www.facebook.com/heartmindi

What does it take to turn a banned psychedelic into an FDA-approved medicine? Visit MAPS to read about the latest progress is psychedelic research: https://maps.org/ In this episode, we speak with Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), about the decades-long mission to make MDMA-assisted therapy a legal treatment for PTSD and other mental health conditions. Rick received his PhD from Harvard's Kennedy School of Government in public policy focusing on the regulation of medical use of psychedelics in 2001. Rick shares the science behind MDMA’s therapeutic effects, the strategy for winning over regulators, and the battles over claims of neurotoxicity. We discuss the history of psychedelic research, the rise of the underground therapy movement, and how clinical trials, policy change, and cultural perception must align to move psychedelics from stigma to science. Whether you’re curious about psychedelic science, drug policy reform, FDA clinical trials, or the future of mental health treatment, this conversation delivers expert insight into the intersection of research, regulation, and real-world impact. Follow us for more technical interviews with the world’s greatest scientists: Twitter: https://x.com/632nmPodcast Instagram: https://www.instagram.com/632nmpodcast?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw== LinkedIn: https://www.linkedin.com/company/632nm/about/ Substack: https://632nmpodcast.substack.com/ Follow our hosts! Michael Dubrovsky: https://x.com/MikeDubrovsky Misha Shalaginov: https://x.com/MYShalaginov Xinghui Yin: https://x.com/XinghuiYin Subscribe: Apple Podcasts: https://podcasts.apple.com/us/podcast/632nm/id1751170269 Spotify: https://open.spotify.com/show/4aVH9vT5qp5UUUvQ6Uf6OR Website: [https://www.632nm.com](https://www.632nm.com/) Timestamps: 00:00 - Intro 01:32 - How Would Rick Describe a Psychedelic Experience? 05:02 - What is Rick's Favorite Psychedelic? 09:46 - The Underground is Ahead of the Research 12:45 - How Rick Got Interested in Psychedelics 26:39 - Can Psychedelics Stop War? 40:45 - Do People Need Trauma? 45:09 - Is America a Falling Empire? 52:08 - What if MAPS was in the YC? 55:00 - Why was MDMA the Choice to Push for Legality? 1:02:22 - The Origins of Modern Psychedelic Therapy 1:05:20 - Misinformation Around Psychedelics 1:17:12 - How MAPS is Developing Psychedelic Therapies 1:30:13 - How Should Healthy People Use Psychedelics? 1:38:05 - Psychedelic Experiences as Rites of Passage 1:42:02 - Finding Life's Purpose 1:52:49 - Why Do Fears of Psychedelics Persist? 1:56:44 - What Does It Take for Psychedelics to Get FDA Approved? 2:13:55 - Rick's Pet Wolf 2:23:39 - Rick's Last Interaction with his Wolf 2:30:55 - Psychedelic Group Therapy 2:33:37 - We Need More Psychedelic Therapists

Trigger Warning: This episode includes discussion of trauma, suicide, abuse, and emotional processing in the context of psychedelic therapy. Please take care while listening. Viewer discretion is advised. You've been told psychedelics are poison. That healing trauma requires years of talk therapy. What if three sessions could change everything? This week on Live Well Be Well, I sit down with Dr. Rick Doblin, who has spent 39 years fighting for something most people thought impossible: bringing psychedelics back into medicine. As the founder of MAPS (Multidisciplinary Association for Psychedelic Studies), Rick has dedicated his life to proving that MDMA isn't just a party drug. It's a revolutionary treatment for trauma that could change how we understand healing itself. Rick doesn't just speak about psychedelics as science or policy. He's lived them, studied them, and helped thousands heal with them. His work isn't about escapism. It's about going deeper. Into the body. Into memory. Into parts of ourselves we've long avoided. And then, through compassion and skilled integration, coming out the other side, changed. We explore: Rick's first psychedelic experience and what it taught him about interconnectedness How MDMA works in the brain to reduce fear and increase compassionWhy MDMA may be the most effective tool we have for PTSD The three-phase therapy protocol and why context matters more than the drug itself What went wrong with FDA approval and why Rick believes approval is inevitable The difference between a "bad trip" and a meaningful one Why people with the most difficult childhoods often show the greatest improvement with MDMA therapy How patients develop empathy (not forgiveness, but understanding) for their perpetrators Your trauma doesn't define you. But learning to hold it with compassion might just set you free. Love, Sarah Ann 💛 *** This episode is sponsored by Spatone – the No.1 iron-rich water supplement. This is a product I genuinely believe in — one I’ve used personally and recommended in the clinic for years. Spatone is a natural iron-rich water that’s incredibly gentle on the stomach. No harsh tablets, no digestive upset — just one naturally sourced ingredient that works. If you’re looking for iron support that actually feels good to take, this is the one I trust. You can pick up Spatone at Boots : Spatone Apple Daily Iron Shots + Vitamin C 28 Sachets - Boots ** This episode is also sponsored by London Nootropics, the best-in-class adaptogenic coffee I trust. Made with Hifas da Terra mushroom extracts, it supports focus, calm, and energy, and helps you stay sharp throughout the day. Enjoy 20% off with code LIVEWELLBEWELL at londonnootropics.com *** If you enjoyed this episode, you might also like: Radhika Das: Unlock Your Vagus Nerve for Better Mental Health https://www.youtube.com/watch?v=8rUi49Iiq0U *** Sign up to Sarah’s Compassionate Cure newsletter: Science Simplified, Health Humanised. Join thousands in exploring actionable insights that prioritise compassion, clarity, and real-life impact. <a href="https://sarahmacklin.substack.com/" target="_blank" rel="ug

Welcome to the Healing Our Politics Podcast! Join Our Community and Receive Free Tools + How to Guides: Join “The Leader’s Handbook” newsletter https://leadershandbook.substack.com/about · Always free · Once per month email · Curated selection of tools, techniques, and practices discussed on this podcast · Delivered in simple to follow how-to-guides · To try and test in your life , and teach your teams. JOIN HERE https://leadershandbook.substack.com/about Guest: Rick Doblin is a man who saw a future no one else believed in: to restore and reimagine the role of psychedelics in society as tools for healing. Today, after nearly four decades of joyful persistence, legal battles, and spiritual grit, that dream is a global movement . Rick is the founder and president of the Multidisciplinary Association for Psychedelic Studies, or MAPS, a nonprofit that’s been at the absolute forefront of psychedelic research since 1986: If you’ve ever had a serious conversation about psychedelic medicine, chances are, you’ve encountered his work — directly or indirectly. Rick holds a Ph.D. in Public Policy from the Harvard Kennedy School, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. Rick has been a featured guest for TED Talks, and the Students for Sensible Drug Policy ,SSPD, and just last year was recognized as one of the most influential people in global health, 2024 TIME 100 Health Honoree. He’s part philosopher, part policy strategist, part spiritual truth seeker, and CONTINUES to be one of the most persistent, thoughtful, and — frankly — courageous advocates for psychedelics as tools for healing. About the Episode : I first sat down with Rick months ago, but in light of the FDA’s decision against MDA assisted psychotherapy, dropping just before the original episode release , I HAD to check in with Rick again for the whole picture. In this exciting two-parter you get Rick’s perspective PRE and POST the FDA’s decision. In the first half, we dig into Rick's 40 year journey, including never before told stories about his early life, the founding of MAPS, what it's like to stay true to a vision no one else believed was possible, and Rick’s decades-long chess game with the FDA. We talk about making bipartisan coalitions last, unconventional approaches to management, how to discern grit from stubbornness, and how to reframe fundraising asked to truly connect with lasting mission aligned support, structuring your organization - for profit, non-profit, or something else- how to turn enemies to allies, and how to fight major institutions and win. In the second half, we discuss how MAPS is paving the way

Perhaps the tools to face death— heal from trauma— and transform life—have been within us all along. In this special episode of Alive Again , host Dan Bush sits down with Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) and one of the most influential voices in psychedelic research today. Together, they explore how psychedelic-assisted therapy is changing the landscape of trauma recovery, end-of-life care, and the very nature of what it means to heal. Rick shares insights from decades of groundbreaking work using MDMA, LSD, and psilocybin in clinical settings—particularly for those facing terminal illness or deep psychological wounds. He discusses brain plasticity, the release of DMT at death, and the profound similarities between near-death experiences and guided psychedelic journeys. With warmth and depth, this episode moves between the personal and the universal—grief, meaning, mortality, and the liminal spaces where transformation begins. Whether you're curious about the science or seeking a deeper understanding of the human spirit, this conversation offers a powerful look at how we might approach death—not with fear, but with expanded awareness. More About Rick Doblin: Rick Doblin is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that has been at the forefront of exploring the therapeutic potential of psychedelics for over 35 years. His groundbreaking work has helped transform how we approach healing, trauma recovery, and end-of-life care, particularly through the use of psychedelics like MDMA, psilocybin, and DMT. Rick’s dedication to this field has given countless individuals— and their families—hope, understanding, and peace in the face of immense challenges, including terminal illness. In our conversation, we explore the intersection of his work with the themes of this podcast: transformation, adaptation, and the profound mysteries surrounding death and near-death experiences. Important links based on our conversation with Rick: Psychedelic Science 2025 MAPS Integration Workbook Donate to MAPS — MAPS relies on financial support from people like you. If you support the advancement of psychedelic research, policy reform, and education, please make a donation to fuel their work. Social Media links: MAPS Instagram: @MAPS__org Facebook: Multidisciplinary Association for Psychedelic Studies (MAPS) Linkedin: Multidisciplinary Association for Psychedelic Studies (MAPS) Twitter (X): @MAPS Threads: @MAPS__org Bluesky: @mapsorg.bsky.social TikTok: @MAPS.org YouTube: @MAPSMDMA Rick Doblin Instagram: @RickDoblinPhD Facebook: Rick Doblin Twitter (X): @RickDoblin Linkedin: Rick Doblin * If you have a transformative experience to share, we’d love to hear your story. Please email us at aliveagainproject@gmail.com See <a href="https://omnystudio.

In this episode of The Psychedelic Podcast, Paul F. Austin welcomes back Rick Doblin, Ph.D., Founder and President of MAPS (Multidisciplinary Association for Psychedelic Studies), for a deeply personal and visionary conversation on the recent FDA rejection of MDMA-assisted therapy. Find full show notes and links here: https://thethirdwave.co/podcast/episode-306/?ref=278 Rick opens up about the painful setbacks, internal missteps, and his own process of recovery and renewed hope. He explains why this isn't the end—but a critical turning point for psychedelic medicine. Rick and Paul unpack the nuances of drug plus therapy, exploring why context, integration, and culture matter as much as pharmacology. They reflect on the future of MAPS, the psychedelic renaissance beyond FDA approval, and how business, politics, and spirituality intersect with healing. The episode also explores Rick's enduring belief in public benefit models, global collaboration, and the potential of a spiritualized humanity. Rick Doblin, Ph.D., is the Founder and President of MAPS. He received his doctorate in Public Policy from Harvard's Kennedy School of Government, and has spent nearly four decades advancing the safe and legal use of psychedelics and marijuana through science, education, and advocacy. Highlights: The cost of MAPS' quiet period Why MDMA therapy was rejected by FDA Pharma vs. therapy: What's best for patients? Drug-only treatments vs. integrated therapy Ibogaine's role in brain healing and PTSD MAPS' path forward: Phase 4 vs. Phase 3 What the Dutch got right about MDMA Spiritualized humanity and self-transcendence The global impact of MAPS' work Business, love, and psychedelic ethics Want to attend this year's Psychedelic Science 2025 Conference? For our community: Use code THIRDWAVE15 for 15% off registration. Learn more and register at psychedelicscience.org — See you there! Episode Links Psychedelic Science 2025 Conference MAPS Website Psychedelic Science on Instagram MAPS on Instagram Psychedelic Science on LinkedIn MAPS on LinkedIn Psychedelic Science on X Episode Sponsors: Golden Rule Mushrooms - Get a lifetime discount of 10% with code THIRDWAVE at checkout Psychedelic Coacing Isntitute's Intensive for Psychedelic Professionals in Costa Rica - a transformative retreat for personal and professional growth.

Christina Kantzavelos is a neurodivergent, and first-generation (third culture) Licensed Clinical Social Worker (LCSW), life coach, writer and chronic illness warrior. She received both her BA and MSW from the University of California Los Angeles (UCLA) and her MLIS from San Jose State University (SJSU). She specializes in treating clients with chronic health conditions (aka spoonies and medical refugees) and trauma (including medical trauma). Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. Learn more about Rick by listening to his Origin Story, watching his TED Talk, and watching his SSDP talk about lessons for political activism from a series of his psychedelic experiences. In This Episode Christina’s website Neural Retraining information Constructed Awareness Rick’s Instagram MAPS Website You can learn more about what I do here: The Trauma Therapist Newsletter: celebrates the people and voices in the mental health profession. And it's free! Check it out here: https://bit.ly/4jGBeSa The Trauma Therapist Podcast: I interview thought-leaders in the fields of trauma, mindfulness, addiction and yoga such as Peter Levine, Pat Ogden, Bessel van der Kolk and Bruce Perry. https://bit.ly/3VRNy8z Become a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support .

This podcast comes from the Aspen Psychedelic Symposium from last summer. It features Diane Goldstein who is the executive director of Law Enforcement Action Partnership, Sarko Gergerian a police officer from Winthrop, Mass and Rick Doblin from MAPS. This panel was introduced by Zach Leary and was a highlight of our trip to Aspen’s conference […] The post Diane Goldstein, Sarko Gergerian and Rick Doblin appeared first on Psychedelics Today .

In this episode of Divergent States , we sit down with Rick Doblin , founder of MAPS (Multidisciplinary Association for Psychedelic Studies), for a raw, unscripted conversation on the future of psychedelic therapy, the dangers of hype, and the deeply personal reasons behind his decades-long mission. We go deep into: Why MDMA was criminalized and how Doblin outmaneuvered the DEA The hard lessons from MAPS' FDA rejection and what's next Parenting and psychedelics: how both Rick and 3L1T3 approach education with their kids The trauma epidemic—why it’s bigger than war, abuse, or addiction How psychedelics could help shift collective consciousness in an age of collapse Burning Man, the Zendo Project, and building a new kind of community Doblin shares stories of his first psychedelic trips, his rebellious roots, and his vision for a future where safe, supported altered states are a human right, not a privilege. This isn’t just policy talk, it’s soul talk. 👉 If you’re neurodivergent, psychedelic-curious, or just fed up with the way things are—this one’s for you. 🧠 Support the show : patreon.com/divergentstates 🎟️ Learn more about Psychedelic Science 2025: maps.org 🔬 Psychedelic Science 25 at https://www.psychedelicscience.org Thank you to our Visionary Collaborators on Patreon! Thank you to Flintwick for the music! Chapters 00:00 Introduction to Divergent States and MAPS 02:47 Rick Doblin's Journey and the Founding of MAPS 10:03 The Messianic Idea and Psychedelics 18:54 Psychedelics as Tools for Healing 19:00 Educating the Next Generation about Psychedelics 25:00 The Role of Psychedelics in Addressing Global Trauma 30:09 Psychedelics and the Future of Humanity 33:31 Revitalizing Spirituality and Cultural Contexts 34:45 Psychedelics and Responsible Use 36:11 Modern Rites of Passage through Music 37:57 Harm Reduction and Support at Festivals 39:19 Psychedelic Science 2025 Conference 41:35 Community and Collaboration in Psychedelic Research 43:42 Reflections on Policy and Progress 45:42 Navigating Politics and Science 49:35 Globalizing Access to Psychedelic Therapies 52:42 The Importance of Divergent Perspectives Send us Fan Mail The next course is a weekend intensive and will take place on June 6th and 7th from 8am-2:30pm PT. This is a great opportunity for professionals and European students to participate in our live training at a more accessible time. FiresideProject.org Download the app or text/call 62-FIRESIDE Zendo Project Our listeners get 10% off the Zendo Project SIT Program with the code DIVERGENTS10 Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you. Support the show Special Thanks to our Macrodosers, Super D and Mike, and our Thumbprint Tier member, Angie on Patreon! https://linktr.ee/3L1T3Mod

Dr. Rick Doblin, founder of Multidisciplinary Association for Psychedelic Studies (MAPS), and Jeff Zucker discuss activism, psychedelics, epigenetics, generational trauma, and more. Watch this episode on YouTube https://youtu.be/xlsVDPRvDtE Chapters: 0:00 - Intro 2:34 - People are the Answer 4:37 - Put it Into Practice 5:56 - Intention 10:24 - Fear and Motivation 12:05 - What Motivates You? 19:45 - How Relatives Coped with the Holocaust 24:36 - Epigenetics of Trauma 26:29 - Giving Back in Early Life 33:43 - Global Spirituality 39:49 - What Lead to Starting MAPS? 52:44 - How Do We Move Forward with MDMA? 57:08 - State Level an Option? 1:00:28 - MAPS Cannabis Project 1:02:18 - Medical Cannabis in SC 1:05:02 - How Do You Avoid Burnout? 1:07:18 - What is MAPS Working on Now? 1:11:04 - Oregon Recriminalization 1:13:17 - Snap Your Fingers 1:15:26 - How to Support Rick Doblin: https://www.linkedin.com/in/rickdoblin/ https://www.instagram.com/rickdoblinphd/ MAPS: https://maps.org/ https://www.linkedin.com/company/mapsnews/ https://www.instagram.com/maps__org/ https://www.facebook.com/mapsmdma https://twitter.com/MAPS https://www.youtube.com/c/mapsmdma https://www.reddit.com/user/MAPSPsychedelic/?rdt=36196 Host: Jeffrey M. Zucker Producer: Kait Grey Editor: Nick Case Recording date: 12/3/24

Consciousness is one of the six themes of the Denizen podcast and the role of psychedelics is an important subset of that inquiry. It's an honor to bring Rick Doblin to the podcast with this episode; he has been at the forefront of the movement since founding the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986. Rick is joined by Nirvan Mullick, filmmaker and founder of Interconnected Media, who has been working on a documentary about Rick and MAPS for ten years. This episode extensively explores the role of storytelling in the psychedelic movement. Rick takes us back to the cultural context of his childhood and shares his own experience of awakening through experimenting with psychedelics as a young adult. We discuss MAPS’s strategy and how storytelling complimented their data-driven approach with clinical trials. We talk about MAPS's corporate structure and how it evolved over time, with its incentives slowly corrupted as MAPS was forced to bring in venture capital to continue its work. Rick shares the story of the year leading up to the FDA's response letter, and how MAPS's leadership inhibited his ability to contribute to a more balanced narrative about the treatment of MDMA for PTSD. We then look forward to what comes next, and how storytelling is critical for the movement to succeed in bringing psychedelics to the mainstream to enable a global shift in consciousness. Throughout, Nirvan shares his insights as a filmmaker documenting Rick's story over the last ten years. To stay connected to all things Denizen, you can sign up for our newsletter at www.becomingdenizen.com . There we share our latest content alongside community events, educational opportunities, and announcements from our many partner organizations.

In this episode, we welcome Rick Doblin, Ph.D., the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. Learn more about Rick by listening to his Origin Story , watching his TED Talk , and watching his SSDP talk about lessons for political activism from a series of his psychedelic experiences. Watch Dr. Doblin's Ted Talk: https://www.ted.com/talks/rick_doblin_the_future_of_psychedelic_assisted_psychotherapy?subtitle=en Listen to his Origin Story: https://www.youtube.com/watch?v=4s_j2OJOhrI&ab_channel=PTTOW%21 Tune into his SSDP Talk: https://www.youtube.com/watch?v=d3X2YsG7-Nc&ab_channel=StudentsforSensibleDrugPolicy%28SSDP%29

Ospite della 131° puntata di Illuminismo Psichedelico è Rick Doblin, fondatore e presidente della Multidisciplinary Association for Psychedelic Studies (MAPS) ed ex membro del consiglio di amministrazione di Lykos Therapeutics. Insieme a Doblin abbiamo parlato della sua scoperta e del suo rapporto con l'MDMA, di come questo abbia ispirato la nascita di MAPS e le ricerche per consentire un uso terapeutico della sostanza, ma anche di come poi le cose siano andate male, a causa della concorrenza di altre entità che chiedevano fondi per ricerche sugli psichedelici MAPS è stata costretta a generare una costola "for profit", Lykos, che ben presto è diventata un "lupo tra i lupi", e Doblin ha deciso di lasciarla, mostrandosi molto critico con come la nuova entità ha scelto di comunicare ma anche di difendere i risultati della fase 3 dei trial sull'MDMA, bocciati nella scorsa estate dalla FDA.

In this episode, Joe interviews Rick Doblin, Ph.D.: founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), and former board member at Lykos Therapeutics, MAPS' public benefit subsidiary. Doblin tells his side of the story: that the FDA's concerns with double blinding not working had been fully addressed ahead of time, that they had negotiated agreements that were no longer agreed to when new FDA employees came on board, that there was a lot of confusion from going back and forth with the FDA on how Phase 3 studies should be designed, and more. He believes that Lykos made a massive mistake in assuming that provable science was more important than public opinion, and that ignoring critics who were saying whatever they wanted caused them to lose control of the narrative – which clearly influenced the advisory committee. While Lykos figures out their next steps with the FDA, MAPS is focusing their attention on what they feel is most important in light of this ruling: better public education and drug policy. He talks about: How there's a bias at the FDA to be harsh: Does automatically saying no just make it look like you're being rigorous? The work of the Dutch government in researching MDMA, and Lykos' odd decision to not highlight any of it Massachusetts' Legalization and Regulation of Psychedelic Substances initiative, and the huge opportunity for progress at the local level Why federal agents at Burning Man work so hard to give tickets to attendees for smoking cannabis Why sharing stories of your positive experiences with psychedelics is so important and more! MAPS has announced that 2025's Psychedelic Science conference will be in Denver, June 16-20, and will have experiential opportunities before and after. For links, head to the show notes page .

When the path to healing hits a roadblock, what’s the next move? Rick Doblin, Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), takes us on a journey through the challenges and triumphs of bringing MDMA-assisted therapy closer to FDA approval. In this episode, learn about the resilience needed to overcome setbacks in the world of psychedelic therapy and the profound impact that combining psychedelics with therapy can have on healing. Rick doesn't shy away from the ethical dilemmas and the complexities of integrating these powerful substances into therapeutic settings. His optimism shines through as he discusses the growing bipartisan support and the cutting-edge research pushing this field forward. With his deep knowledge and unwavering commitment, Rick offers a glimpse into the future of psychedelic therapy that’s both realistic and hopeful. For anyone invested in consciousness expansion and the potential of psychedelics to transform lives, this conversation is not one to miss. Rick’s insights are a powerful reminder that the road to innovation is often challenging, but the rewards can be life-changing. Key Takeaways: [00:02:34] FDA setback and resilience. [00:06:24] FDA regulation concerns psychedelics. [00:08:35] Unleashing potential in leadership. [00:13:14] Psychedelics for compassionate use. [00:16:26] Couples therapy research. [00:20:07] Public education on psychedelics. [00:23:27] Drug policy reform efforts. [00:26:22] FDA's view on psychedelics. [00:30:25] Ethical considerations in psychedelic therapy. [00:34:25] Group therapy for cost-effective treatment. [00:37:30] Healing through relationships. [00:41:27] Psychedelic research setbacks. [00:43:23] Psychedelics and human consciousness. [00:46:31] Psychedelics and public perception. [00:51:14] Evolution of consciousness. Memorable Quotes: "If you believe that this sort of consciousness change is really important, it's something to recognize that psychedelics have been used for thousands of years — and even when they've been massively suppressed, they've never been able to be eliminated. There's something about psychedelics and human beings where some fraction of human beings will seek them out and will find benefits." [00:42:58] – Rick Doblin "I think it's about really this multiplicity of catalysts and the responsibility that we have as humans in this particular time of humanity is to really up our game and to think of ourselves collectively. We see what's happening with global warming — we see what's happening with nuclear weapons — we see what's happening with all sorts of concerns. And we need to figure out how to think as a collective, as humanity as a whole, instead of as my individual race, religion, nationality, socioeconomic status. And I think psychedelics and other things can help us with that." [00:51:03] – Rick Doblin Connect with Rick Doblin: Website: https://maps.org/ Instagram: https://www.instagram.com/rickdoblinphd Facebook: https://www.facebook.com/rickdoblin/ Twitter: https://x.com/rickdoblin Emails: rick@maps.org and Whitney@maps.org Connect with Modern Enlightenment:

Dr. Rick Doblin is the founder and former Executive Director of MAPS (Multidisciplinary Association for Psychedelic Studies)​ (Wikipedia)​. He has been a key figure in advancing research into the therapeutic potential of psychedelics and has been instrumental in promoting the legalization of psychedelics for medical use​ (MAPS)​. Dr. Rick Doblin's Work and Achievements: MAPS and Psychedelic Therapy: Dr. Doblin founded MAPS in 1986 with a vision to integrate psychedelics into the medical field for therapeutic uses. Under his leadership, MAPS has conducted pioneering research into the benefits of psychedelics, particularly MDMA, for treating various mental health conditions​ (Apple)​. Clinical Trials and Research: MAPS has completed Phase 3 trials for MDMA-assisted therapy for PTSD and continues to explore its efficacy across various contexts. Dr. Doblin’s research includes advocating for the legalization of MDMA-assisted therapy and educating medical professionals on its benefits​ (Psychedelics Today)​. Advocacy and Impact: Beyond research, Dr. Doblin has advocated for policy changes regarding psychedelics, emphasizing their potential to aid in treating mental health disorders and changing the perception of these substances​ (Nature)​. Documentary and Public Engagement: Dr. Doblin’s life and work are captured in the documentary "Prescription X," highlighting his journey to legalize psychedelics for therapeutic use, including the challenges and triumphs along the way​ (PS2023: The Virtual Trip)​. In this week's episode of "Road to Abundance," we welcome Dr. Rick Doblin, the founder of MAPS. We delve into his work in the field of psychedelic research, exploring how MAPS has paved the way for the integration of psychedelics into medical therapy. We discuss the ongoing trials and the benefits of psychedelic therapy for mental health, as well as Dr. Doblin’s advocacy for legalization. Join us for an enlightening conversation on the changing landscape of psychedelic medicine and its potential to revolutionize mental health treatment.Twitter: Rick Doblin Twitter - https://twitter.com/rickdoblin

Rick Doblin is the founder of MAPS (multidisciplinary association for psychodelic studies), which just complete phase 3 trials for using MDMA to treat PTSD. They have an astounding success rate curing PTSD with 67% and addition 21% seeing good progress towards healing... thats 88% success in helping people live better lives. https://www.maps.org

Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio. Today, I am speaking with Rick Doblin , founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). December of last year was a milestone for Doblin and MAPS, as the organization submitted a New Drug Application for MDMA Assisted Therapy to the United States Food and Drug Administration. Then, in the first week of January, the MAPS Public Benefit Corp announced its rebranding to Lykos Therapeutics and a $100 million Series A financing. Needless to say, it has been a pivotal period in the organization’s history and a watershed moment for the revival of psychedelic medicine, science, and policy. In February, the FDA accepted the application and granted a priority review, putting the decision timeline at August of this year. That’s just around the corner. And so much is still up in the air—of course the big question—will the FDA grant approval? But also so many granular details that will have significant downstream effects on the commercial rollout, access, and cost. * What language will be on the drug label? * What will the Risk Evaluation and Mitigation Strategy entail? * How will patients be able to access the drug? * What will the FDA say about the role of therapy? Among others. So, I wanted to sit down with Rick to talk about it and get his perspective on the organization’s evolution, the path ahead, and, most importantly, the many uncertainties that hang in the balance. In this conversation, we discuss: * The importance of therapy in conjunction with MDMA (and his loathing of the acronym MDMA-AT) * The many regulatory and bureaucratic details that go into the FDA’s decision and subsequent commercial rollout, including: * Drug labeling * Therapist credentialing * Risk Evaluation and Mitigation Strategies * The negotiations he’s led with the FDA over the last 20 years * Lykos’ goal of getting MDMA-Assisted Therapy FDA approved and MAPS’ goal of getting MDMA federally legalized * The role of therapist’s first-hand experience with MDMA and the regulatory battle of ensuring legal access to this group * His future humanitarian and scientific plans And much more. And now I bring you my conversation with Rick Doblin. Listen to the episode on Substack , Spotify , Google or Apple . Credits: * Hosted by Zach Haigney * Produced by Zach Haigney, Erin Greenhouse , and Katelin Jabbari * Find us at thetripreport.com * Follow us on <a target="_blank" href="https://ww

Rick Doblin, Ph.D., is the Founder & President of the Multidisciplinary Association for Psychedelic Studies (MAPS) and this episode is all about his life and work. This episode is a holistic look at the point where traditional therapy meets psychedelics and how Doblin and his team have spent the last few decades appealing to the scientific community and lawmakers across the world. Doblin gives us a fresh perspective on the mental health crisis and discusses his studies & experiments in Iceland. We cover his early professional life and what lead him to pursue the science of alternative medicines. Doblin believes that with psychedelic assisted therapy, the world could be trauma free by 2070. Are you interested in learning more about this type of therapy? Shawn received his treatment here - https://ambio.life Shawn Ryan Show Sponsors: https://lairdsuperfood.com - USE CODE " SRS " https://helixsleep.com/srs - USE CODE " HELIXPARTNER20 " https://ziprecruiter.com/srs https://hillsdale.edu/srs https://moinkbox.com/shawn https://blackbuffalo.com https://meetfabric.com/shawn https://ShawnLikesGold.com | 855-936-GOLD #goldcopartner Rick Doblin Links: MAPS - https://maps.org/about-maps/mission/ Get Involved - https://maps.org/take-action/ Instagram - https://www.instagram.com/rickdoblinphd/ Learn More - https://sprout.link/rickdoblinphd Please leave us a review on Apple & Spotify Podcasts. Vigilance Elite/Shawn Ryan Links: Website | Patreon | TikTok | Instagram | Download Learn more about your ad choices. Visit podcastchoices.com/adchoices

In today's new Radical Responsibility Podcast episode, join Dr. @FleetMaull and Rick Doblin, PhD, on "Prohibition to Progress: The Evolving Landscape of Psychedelics." Fleet and Rick Doblin discuss the changing cultural attitude towards psychedelics, uniting diverse groups—scientists, politicians, and veterans. They explore how psychedelics can be integrated into mainstream culture, offering potential solutions to global challenges and potentially revolutionizing mental health treatment approaches. They also examine the shift towards group therapy, especially in treating conditions like PTSD, and its implications for the future. Rick Doblin, PhD, is the founder and executive director of MAPS (Multidisciplinary Association for Psychedelic Studies), We Also Discuss: Explore the changing cultural attitude towards psychedelics, bringing together diverse groups of people, including scientists, politicians, and veterans. Learn how psychedelics can be integrated into mainstream culture as a potential solution for various global challenges. Understand the significance of focusing on durable results in psychedelic therapies, potentially transforming how we approach mental health treatment. Examine the shift towards group therapy as a new approach for psychedelics, especially in treating conditions like PTSD, and its implications for the future. Explore the complex journey of psychedelic legalization, involving rescheduling at both federal and state levels and the potential impact on accessibility and affordability.

Today we are joined by psychedelic activist and founder of MAPS, Rick Doblin. In this conversation, Alli and Rick discuss the hopeful potential of bringing psychedelics to the masses for celebration, healing, and changing the world. Rick shares his personal insights from MDMA and LSD, reflecting on the fact of death and how realizing it's impermanence helped him live a better life. He shares how psychedelics can be used for heart-opening and healing PTSD. He and Alli discuss the process of legalization and the importance of languaging when it comes to speaking to the masses. He also shares the inspiring journey of founding MAPS and how the vision has expanded over time. === TIMESTAMPS: 0:00 Intro 2:32 Facing the Fact of Death 6:31 Rick’s LSD Awakening to Life’s Impermanence 20:23 The Essence of MDMA: Opening the Heart 33:28 Similarities of Meditation & MDMA 35:30 Using Psychedelics to Process Trauma in Real Time 49:56 Language Used in Psychedelic Policy 1:02:16 Speaking to the Masses Across Party Lines 1:16:00 The Journey of MAPS & What’s Coming Next 1:34:06 Conscious Capitalism: Changing the Way We See Profit 1:41:00 “This Timeless Moment” Reflecting on Death 1:43:58 Rick’s Most Important Lesson from Psychedelics 1:45:30 Conclusion === Rick Doblin: MAPS: https://maps.org Rick's Instagram: https://www.instagram.com/rickdoblinphd/ === Step into the Multiverse with us... Shop Supermush: https://supermush.com/ our in house brand of the most effective and delicious functional mushroom supplements. Use Code: ITM15 for 15% off Into the Multiverse Instagram: https://www.instagram.com/intothemultiverse/ Super Mush Instagram: https://www.instagram.com/supermush/

Welcome to the podcast of ALPS, the conference that wants to make us aware of psychedelic science and its effects on the psyche. A whole program held in Geneva for 2023, with many speakers from Switzerland, Europe and all over the world. In this episode, syde & WarcoBrienza welcome Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). A ‘godfather’ of psychedelics - as syde would name him - since 1985. In the podcast, we discuss with Rick Doblin and Federico Seragnoli, cofounder of the ALPS conference, the results of 2 MAPS-sponsored, philanthropy-funded Phase 3 clinical trials of MDMA-assisted therapy for Post-traumatic stress disorder (PTSD). As MAPS approaches a decision by the U.S. Food and Drug Administration (FDA) regarding MDMA-assisted therapy for PTSD as soon as mid-2024, we explore the context of the MDMA prohibition that occurred in the 80’, as well as the possibility of a world of net-zero trauma by 2070. More details on Odiolab's website: www.odiolab.ch/series/alps-podcast

Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS) . He founded MAPS in 1986 and is considered the godfather of the current psychedelic renaissance. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. It’s thanks to his MAPS organization that MDMA is currently at phase 3 trial in the US and will be normally approved by the FDA to treat PTSD patients in 2024. For more info on Rick Doblin : MAPS Founder and President Twitter X : @RickDoblin TED Talk : the future of psychedelic-assisted psychotherapy This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023. More info on the Alps Conference 2023 - ⁠Website⁠ - ⁠Twitter⁠ - ⁠Facebook⁠ - ⁠Instagram⁠ - ⁠Youtube

In this episode, syde & WarcoBrienza welcome Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). A ‘godfather’ of psychedelics - as syde would name him - since 1985. In the podcast, we discuss with Rick Doblin and Federico Seragnoli, cofounder of the ALPS conference, the results of 2 MAPS-sponsored, philanthropy-funded Phase 3 clinical trials of MDMA-assisted therapy for Post-traumatic stress disorder (PTSD). As MAPS approaches a decision by the U.S. Food and Drug Administration (FDA) regarding MDMA-assisted therapy for PTSD as soon as mid-2024, we explore the context of the MDMA prohibition that occurred in the 80’, as well as the possibility of a world of net-zero trauma by 2070. Questions to Rick Doblin & Federico Seragnoli: You are one the Godfather of the Psychedelic Renaissance, how does it feel to see your life’s work being recognised? Live from Geneva at the ALPS Conference 2023, what was the importance of Switzerland in 1986 when you founded the MAPS Association ? What are the most promising regions of the world in terms of psychedelics for therapeutic use ? How can drugs reinforce the spiritual experience? Biography of Rick Doblin Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. This interview was recorded during the Alps Conference 2023 on psychedelic research in Geneva, Switzerland on 27.10.2022. More info on the Alps Conference here